city Bristol covid-19 testing vaccine city Bristol

University of Bristol, Imophoron to test Covid-19 vaccine candidates

Reading now: 909
www.pharmaceutical-technology.com

The University of Bristol and spin-out firm Imophoron are set to assess Covid-19 vaccine candidates in-vivo in a pre-clinical programme.

Imophoron has generated several candidates based on its ADDomer vaccine platform, a synthetic, self-assembling, virus-like particle (VLP).

The company collaborated with the University of Bristol’s Covid-19 Emergency Research (UNCOVER) Group and will lead the vaccine development.

Preclinical tests are expected to begin within weeks. Imophoron founder and CEO Frederic Garzoni said: “We have optimised our process and can now design and roll-out potential vaccines in about two weeks, ready for testing. “With our technology, we hope to contribute to resolving the major health and economic threats caused by

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA